Market Overview:
The global sepsis diagnostics market size reached US$ 687.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,404.3 Million by 2032, exhibiting a growth rate (CAGR) of 8.3% during 2024-2032.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 687.2 Million |
Market Forecast in 2032
|
US$ 1,404.3 Million |
Market Growth Rate 2024-2032 |
8.3% |
Sepsis is a medical condition caused due to the body’s response to fight infections that are based on contamination with bacteria, viruses, or fungi. In this condition, the immune system releases several chemicals into the bloodstream that trigger hyper inflammation and the formation of blood clots in the body. Sepsis may result in multiple organ failures, irregular breathing, low blood pressure, neurological dysfunction, faster heart rate, etc. The diagnostic procedures for sepsis primarily include molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, etc. These diagnostic technologies are widely adopted across hospitals, pathology and reference laboratories, academic research institutes, etc.
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Sepsis Diagnostics Market Trends:
The growing prevalence of hospital-acquired infections (HAIs) that causes sepsis, particularly among the geriatric population, infants, and patients suffering from chronic illness, is currently driving the demand for sepsis diagnostics. Furthermore, the rising incidences of numerous infectious diseases caused due to antibiotic-resistant bacteria, including gram-positive bacteria and gram-negative bacilli, are also propelling the need for sepsis diagnostics. Additionally, the expanding healthcare sector along with the increasing penetration of advanced data analytics tools is further catalyzing the sepsis diagnostics market growth. These data analytics tools have enabled the integration of multiple test results from diverse platforms, thereby providing real-time data access and accurate disease diagnosis. Moreover, several technological advancements have led to the emergence of novel immunological and molecular biomarkers that enable the early detection of sepsis. In line with this, the rising investments in extensive R&D activities that include new blood culture approaches for identifying and treating chronic infections are also driving the market for sepsis diagnostics.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global sepsis diagnostics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on diagnosis, product, mode of testing, technology, pathogen and end user.
Breakup by Diagnosis:
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Automated Diagnostics
- Conventional Diagnostics
Breakup by Product:
- Instruments
- Assay Kits and Reagents
- Blood Culture Media
- Software
Breakup by Mode of Testing:
- Laboratory Tests
- Point-of-Care Tests
Breakup by Technology:
- Molecular Diagnostics
- Immunoassays
- Biomarkers
- Flow Cytometry
- Microfluidics
- Blood Culture
Breakup by Pathogen:
- Bacterial Sepsis
- Gram-Positive Bacterial Sepsis
- Gram-Negative Bacterial Sepsis
- Viral Sepsis
- Fungal Sepsis
- Others
Breakup by End User:
- Diagnostic Clinics
- Hospitals
- Research Laboratories
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
- Asia Pacific
- China
- India
- Japan
- Australia
- Singapore
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Becton, Dickinson and Company (BD), biomerieux SA, Bruker Corporation, EKF Diagnostics Holding Plc, Epic Systems Corporation, Luminex Corporation, Roche Holding AG, Sysmex Corporation, and T2 Biosystems Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Segment Coverage |
Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, Australia, Singapore, Brazil, Mexico, Argentina, Saudi Arabia, United Arab Emirates, South Africa |
Companies Covered |
Abbott Laboratories, Becton, Dickinson and Company (BD), biomerieux SA, Bruker Corporation, EKF Diagnostics Holding Plc, Epic Systems Corporation, Luminex Corporation, Roche Holding AG, Sysmex Corporation, and T2 Biosystems Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global sepsis diagnostics market performed so far and how will it perform in the coming years?
- What is the impact of COVID-19 on the global sepsis diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the diagnosis?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the mode of testing?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the pathogen?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the market?
- What is the structure of the global sepsis diagnostics market and who are the key players?
- What is the degree of competition in the market?